Life Science Corporate Compliance Conference to Have DOJ Representation, Global Insight

Chicago, IL, March 12, 2015 --(PR.com)-- Pharmaceutical and medical device executives will have the opportunity to discuss the latest practices and regulations in remaining compliant at the Life Science Corporate Compliance: Big Data Analysis, Transfer of Value and Global Regulation Conference, May 7-8, 2015 in Chicago. This conference will offer a wide array of discussion topics on both a national and international scale, opportunities for networking, and small group workshops for idea sharing.

Corporate compliance experts from all corners of the life science industry will be on hand to lead presentations, case studies, workshops and panel discussions, and include Sujata T. Dayal of Johnson & Johnson, Erik Egilite of Lundbeck, Michael O’Connor of Boehringer Ingelheim. Topics that will be addressed include tracking relevant data, managing compliance risk through data reporting analysis, value reporting program development and implementation, and more. Delegates will have ample opportunity for Q&A and interactive discussion among peers, as well as take away immediately implementable ideas that will offer a competitive advantage.

Representation from the United States Department of Justice will be leading sessions that explore the latest regulatory compliance enforcement trends in the US, as well as leading an interactive workshop where conference delegates will have the opportunity to address common challenges and gain DOJ-suggested best practices and insight on remaining on the leading edge of compliance regulations.

For more information on the Life Science Corporate Compliance: Big Data Analysis, Transfer of Value and Global Regulation Conference, please visit www.q1productions.com/lscompliance or email marketing@q1productions.com. You can also follow the conference on Twitter @Q1Productions, #LSComp15.

About the Organizer:
Q1 Productions designs and develops webinars, training courses, conference programs and forums aimed at specifically targeted audiences throughout highly regulated industries in order to provide strategic learning and timely program content. Through a highly structured production process focused on research calls with end-users and key stakeholders in the industry, our team is able to understand the immediate business concerns of today’s leading executives. Whether focusing on new or pending legislative and health policy issues or enhanced technologies or processes that will drive efficiency, our programs provide solutions to the urgent educational and information needs of our attendees.